Literature DB >> 12190885

Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review.

E Ernst1.   

Abstract

The popularity of Chinese herbal medicines (CHMs) demands a critical analysis of safety issues. The aim of this systematic review is to summarize data regarding adulterations of CHMs with conventional drugs. Literature searches were carried out in six databases. Articles containing original data on adulterations were considered without language restrictions. Eighteen case reports, two case series and four analytical investigations were identified. The list of adulterants contains drugs associated with serious adverse effects like corticosteroids. In several instances, patients were seriously harmed. One report from Taiwan suggests that 24% of all samples were contaminated with at least one conventional pharmacological compound. It is concluded that adulteration of CHMs with synthetic drugs is a potentially serious problem which needs to be addressed by adequate regulatory measures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190885     DOI: 10.1046/j.1365-2796.2002.00999.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  47 in total

1.  Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study.

Authors:  Chao-Hua Chuang; Pat Doyle; Jung-Der Wang; Pei-Jen Chang; Jung-Nien Lai; Pau-Chung Chen
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention.

Authors:  Y-L Kuo; S-J Shieh; H-Y Chiu; J-W Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

3.  Chinese slimming capsules containing sibutramine sold over the Internet: a case series.

Authors:  Dieter Müller; Wolfgang Weinmann; Maren Hermanns-Clausen
Journal:  Dtsch Arztebl Int       Date:  2009-03-27       Impact factor: 5.594

Review 4.  Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews.

Authors:  Paul Posadzki; Leala Watson; Edzard Ernst
Journal:  Eur J Clin Pharmacol       Date:  2012-07-29       Impact factor: 2.953

Review 5.  Integrated analytical assets aid botanical authenticity and adulteration management.

Authors:  Charlotte Simmler; James G Graham; Shao-Nong Chen; Guido F Pauli
Journal:  Fitoterapia       Date:  2017-11-22       Impact factor: 2.882

6.  Adulteration of herbal antidiabetic products with undeclared pharmaceuticals: a case series in Hong Kong.

Authors:  Chor Kwan Ching; Ying Hoo Lam; Albert Y W Chan; Tony W L Mak
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 7.  Potential ecological footprints of active pharmaceutical ingredients: an examination of risk factors in low-, middle- and high-income countries.

Authors:  Rai S Kookana; Mike Williams; Alistair B A Boxall; D G Joakim Larsson; Sally Gaw; Kyungho Choi; Hiroshi Yamamoto; Shashidhar Thatikonda; Yong-Guan Zhu; Pedro Carriquiriborde
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

8.  Herbal medicine-related hepatotoxicity.

Authors:  Evangelos Stournaras; Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2015-09-08

Review 9.  Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Axel Eickhoff; Johannes Schulze
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

10.  Dietary supplements and herbal medicine toxicities-when to anticipate them and how to manage them.

Authors:  D H Phua; A Zosel; K Heard
Journal:  Int J Emerg Med       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.